Work

Cardiac Involvement in Storage Disorders: Pathophysiology, Multimodality Diagnosis, and Emerging Disease-Modifying Therapies

Year: 2026
Type: article
Abstract: Cardiac involvement is a major determinant of morbidity and mortality in storage disorders, including Fabry disease, Pompe disease, Danon disease, PRKAG2 syndrome, transthyretin and light-chain amyloidosis, the mucopolysaccharidoses, Gaucher disease, and Niemann-Pick disease. Because their cardiac phenotype mimics hypertensive heart disease, athlete's heart, and sarcomeric hypertrophic cardiomyopathy, these conditions are often recognised only after irreversible myocardial fibrosis has developed, when disease-specific therapy is least effective. This narrative review aims to summarise the pathophysiology, disease-specific phenotypes, multimodality imaging, molecular diagnosis, and current and emerging treatment of storage cardiomyopathies, framed around the clinical problem of unexplained left ventricular hypertrophy and restrictive physiology. Relevant literature was identified through PubMed/MEDLINE, Embase, Scopus, and Web of Science, supplemented by hand-searching of guidelines and consensus statements, with priority given to randomised trials, registries, and expert consensus. Although their upstream biology differs, storage cardiomyopathies converge on common pathways of substrate accumulation, lysosomal and mitochondrial dysfunction, fibrosis, and electrical instability. Native T1 and T2 mapping, extracellular volume quantification, late gadolinium enhancement, strain echocardiography, and bone scintigraphy now permit earlier and more specific diagnosis. Enzyme replacement therapy, pharmacological chaperones, transthyretin stabilisers, and RNA-targeted agents are most effective when started before fibrosis is established, whereas gene replacement and genome editing remain investigational. Early recognition through structured multimodality imaging and molecular diagnosis, combined with multidisciplinary care, is essential to ensure timely disease-specific therapy and improve long-term outcomes.
Language: English
Field: Medicine
Open Access status: diamond
OpenAlex ID: W7233537368
FWCI:
Cites: 37
Cited by:
Related to: 10